General Information of the Protein
Protein ID |
PT00836
|
||||
---|---|---|---|---|---|
Protein Name |
Carbonic anhydrase 2
|
||||
Secondarily Protein Name |
Carbonate dehydratase II
Carbonic anhydrase C
Carbonic anhydrase II
Cyanamide hydratase CA2
|
||||
Gene Name |
CA2
|
||||
Sequence |
MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Enzyme
>
Lyase
|
||||
Function |
Catalyzes the reversible hydration of carbon dioxide (PubMed:1909891, PubMed:1910042, PubMed:1336460, PubMed:8485129, PubMed:8399159, PubMed:8218160, PubMed:8262987, PubMed:8451242, PubMed:7901850, PubMed:7761440, PubMed:8639494, PubMed:9265618, PubMed:17330962, PubMed:9398308, PubMed:11327835, PubMed:12056894, PubMed:17346964, PubMed:12171926, PubMed:15453828, PubMed:16214338, PubMed:15865431, PubMed:16106378, PubMed:15300855, PubMed:15667203, PubMed:18942852, PubMed:11831900, PubMed:17251017, PubMed:17314045, PubMed:18618712, PubMed:1336460, PubMed:11802772, PubMed:14736236, PubMed:16290146, PubMed:16759856, PubMed:16807956, PubMed:16686544, PubMed:17705204, PubMed:17127057, PubMed:17540563, PubMed:17588751, PubMed:18266323, PubMed:18024029, PubMed:18162396, PubMed:18374572, PubMed:18640037, PubMed:18481843, PubMed:19170619, PubMed:19186056, PubMed:19206230, PubMed:19778001, PubMed:19520834). Can also hydrate cyanamide to urea (PubMed:10550681, PubMed:11015219). Stimulates the chloride-bicarbonate exchange activity of SLC26A6 (PubMed:15990874). Essential for bone resorption and osteoclast differentiation (PubMed:15300855). Involved in the regulation of fluid secretion into the anterior chamber of the eye. Contributes to intracellular pH regulation in the duodenal upper villous epithelium during proton-coupled peptide absorption.
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Subcellular Location |
Cytoplasm
Cell membrane
|
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000025 , HEK-293T
Biochemical Assays
Clinical Information about the Protein
Target 1 ( Carbonic anhydrase II (CA-II) )
Target Type | Successful Target | ||||
---|---|---|---|---|---|
Disease | 11 Target-related Diseases | 11 | |||
1 | High blood pressure [ICD-11: BA00] | ||||
2 | Congestive heart failure [ICD-11: BD10] | ||||
3 | Chronic glaucoma [ICD-11: 9C61.0Z] | ||||
4 | Open-angle glaucoma [ICD-11: 9C61] | ||||
5 | Glaucoma/ocular hypertension [ICD-11: 9C61] | ||||
6 | Seborrhoeic dermatitis [ICD-11: EA81] | ||||
7 | Bacterial infection [ICD-11: 1A00-1C4Z] | ||||
8 | Arthritis [ICD-11: FA20] | ||||
9 | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||
10 | Breast cancer [ICD-11: 2C60-2C65] | ||||
11 | Osteoporosis [ICD-11: FB83.0] | ||||
Approved Drug(s) | 8 Approved Drugs | 8 | |||
1 | Benzthiazide | Approved | |||
2 | Chlorothiazide | Approved | |||
3 | Cyclothiazide | Approved | |||
4 | Dichlorphenamide | Approved | |||
5 | Dorzolamide | Approved | |||
6 | Ethoxzolamide | Approved | |||
7 | Salicyclic acid | Approved | |||
8 | Sulfamylon | Approved | |||
Clinical Trial Drug(s) | 4 Clinical Trial Drugs | 4 | |||
1 | CG-100649 | Phase 3 | |||
2 | Curcumin | Phase 3 | |||
3 | Coumate | Phase 2 | |||
4 | STX-140 | Phase 2 | |||
Investigative Drug(s) | 1 Investigative Drug | 1 | |||
1 | CL-5343 | Investigative |